Auris Medical Holding AG Achieves 50% Enrolment Milestone in Post-Acute Tinnitus Stratum of TACTT3 Clinical Trial

ZUG, Switzerland -- Auris Medical Holding AG (NASDAQ: EARS) today announced that it has enrolled the first 150 patients with post-acute tinnitus in Stratum B of the Company's ongoing TACTT3 clinical trial, ...



from Content Keyword RSS http://ift.tt/1Cjks0s

via IFTTT